| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |